| Literature DB >> 16199995 |
Taiga Nishihori1, May Abdo-Matkiwsky, Stewart B Fleishman, Ronald H Blum.
Abstract
Interferon (IFN)-alpha 2b is used for adjuvant therapy in malignant melanoma. Neurotoxicity as a side effect has been well described. Resting and action tremor related to interferon have been reported but are relatively uncommon. We report a case of a delayed-onset interferon-related action tremor in a patient with malignant melanoma.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16199995 DOI： 10.1097/01.coc.0000145982.86749.b4
Source DB: PubMed Journal: Am J Clin Oncol ISSN： 0277-3732 Impact factor: 2.339